Target intelligence / Profile preview

BTB domain containing 10 pseudogene 1 (BTBD10P1)

Target
BTBD10P1
Molecular classification
Other (Pseudogene)
01

Overview

BTB domain containing 10 pseudogene 1 (BTBD10P1) is a classified pseudogene, meaning it is a DNA sequence that is similar to a known protein-coding gene (in this case, likely similar to BTB domain containing 10, or BTBD10), but contains mutations or deletions that prevent it from coding a functional protein[4]. There is currently no evidence that BTBD10P1 encodes a functional receptor, enzyme, or other canonical therapeutic target. By definition, pseudogenes may sometimes produce non-coding transcripts that regulate their "parent" genes through RNA mechanisms—acting as competitive endogenous RNAs or so-called "miRNA decoys"—though this behavior is well-established only for specific pseudogenes such as PTENP1 and not specifically for BTBD10P1[1][7]. There are no established biological or disease roles, drug interactions, or uses as a biomarker or therapeutic target for BTBD10P1. The BTB/POZ domain is a protein–protein interaction motif found in many transcriptional regulators; the parent gene BTBD10 (not the pseudogene) has some published functional biology[2][3]. The "P1" suffix denotes a pseudogene; such loci are typically non-coding[4]. There is no evidence that BTBD10P1 encodes a protein or has therapeutic target status. Pseudogenes as a class have received interest for potential regulatory and disease relevance, but BTBD10P1 is not established in this way[1][7]. BTBD10P1 is a non-coding pseudogene, not a validated therapeutic target, receptor, or protein-coding gene. No interacting drugs, mechanism of action, biomarkers, or disease involvement is known for this locus at present[4].

Other names
BTB (POZ) domain containing 10 pseudogene 1BTBD10P1
02

Biological functions

Unknown
03

Disease associations

None directly established

Beyond the preview

Go deeper on BTB domain containing 10 pseudogene 1 (BTBD10P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BTB domain containing 10 pseudogene 1 (BTBD10P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call